EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression

J Mingardi, R Molteni, F Bifari

Pharmacological Research · 2026-08 · 230 · 108290

DOI: 10.1016/j.phrs.2026.108290 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pharmacological Research, 2026-08. Verfasst von J Mingardi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Translational Medicine, University of Milan, Italy. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIUR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

5-HT2MASLDMajor Depressive DisorderObesityPsilocybinType 2 Diabetes Mellitus

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Translational Medicine, University of Milan, Italy.
  • Department of Medical Biotechnology and Translational Medicine, University of Milan, Italy. Electronic address: francesco.bifari@unimi.it.

Förderung

  • MIUR

Zitieren

APA

Mingardi, J., Molteni, R., & Bifari, F. (2026). Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression. Pharmacological Research, 230, 108290. https://doi.org/10.1016/j.phrs.2026.108290

Vancouver

Mingardi J, Molteni R, Bifari F. Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression. Pharmacological Research. 2026;230:108290. doi:10.1016/j.phrs.2026.108290

BibTeX
@article{Mingardi2026,
  author = {Mingardi, J and Molteni, R and Bifari, F},
  title = {Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression},
  journal = {Pharmacological Research},
  year = {2026},
  volume = {230},
  pages = {108290},
  doi = {10.1016/j.phrs.2026.108290}
}
Kostenlos starten →